ArticlePloS one2022
A model for isoform-level differential expression analysis using RNA-seq data without pre-specifying isoform structure.
Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 6 citations in OpenAlex.
- Sheep Genetic Resistance to Gastrointestinal Nematode Infections: Current Insights from Transcriptomics and Other OMICs Technologies-A Review.Pathogens (Basel, Switzerland) · 2026Review
- Full-length mRNA sequencing resolves novel variation in 5' UTR length for genes expressed during human CD4 T-cell activation.Immunogenetics · 2025Article
- The roles of different gene expression regulators in acoustic variation in the intermediate horseshoe bat revealed by long-read and short-read RNA sequencing data.Current zoology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
motivationNext generation sequencing (NGS) technology has been widely used in biomedical research, particularly on those genomics-related studies. One of NGS applications is the high-throughput mRNA sequencing (RNA-seq), which is usually applied to evaluate gene expression level (i.e. copies of isoforms), to identify differentially expressed genes, and to discover potential alternative splicing events. Popular tools for differential expression (DE) analysis using RNA-seq data include edgeR and DESeq. These methods tend to identify DE genes at the gene-level, which only allows them to compare the total size of isoforms, that is, sum of an isoform's copy number times its length over all isoforms. Naturally, these methods may fail to detect DE genes when the total size of isoforms remains similar but isoform-wise expression levels change dramatically. Other tools can perform isoform-level DE analysis only if isoform structures are known but would still fail for many non-model species whose isoform information are missing. To overcome these disadvantages, we developed an isoform-free (without need to pre-specify isoform structures) splicing-graph based negative binomial (SGNB) model for differential expression analysis at isoform level. Our model detects not only the change in the total size of isoforms but also the change in the isoform-wise expression level and hence is more powerful.
resultsWe performed extensive simulations to compare our method with edgeR and DESeq. Under various scenarios, our method consistently achieved a higher detection power, while controlling pre-specified type I error. We also applied our method to a real data set to illustrate its applicability in practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.